Meta-analysis of statins in chronic kidney disease: who benefits? (Q38878462)

7 September 2017

0 references

Meta-analysis of statins in chronic kidney disease: who benefits? (English)

1 reference

chronic renal insufficiency

7 September 2017

1 reference

1 reference

C M Messow

1

1 reference

PubMed ID

28340216

7 September 2017

C Isles

series ordinal

2

1 reference

PubMed ID

28340216

7 September 2017

language of work or name

English

0 references

publication date

14 March 2017

1 reference

QJM: An International Journal of Medicine

7 September 2017

1 reference

Dyslipidemia in Dialysis Patients

7 September 2017

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCX040

Cardiovascular and noncardiovascular mortality among patients starting dialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCX040

Effect of fluvastatin on cardiac outcomes in renal transplant recipients: a multicentre, randomised, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCX040

Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCX040

The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCX040

Benefits and harms of statin therapy for persons with chronic kidney disease: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCX040

Lipid-lowering therapy in persons with chronic kidney disease: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCX040

Effect of Statins on Kidney Disease Outcomes: A Systematic Review and Meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCX040

Effect of statin therapy on cardiovascular and renal outcomes in patients with chronic kidney disease: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCX040

Meta-analysis of lipid-lowering therapy in maintenance dialysis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCX040

Statins and Cardiovascular Primary Prevention in CKD: A Meta-Analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCX040

High-intensity statin therapy in patients with chronic kidney disease: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCX040

Effect of lovastatin on primary prevention of cardiovascular events in mild CKD and kidney function loss: a post hoc analysis of the Air Force/Texas Coronary Atherosclerosis Prevention Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCX040

Effects of atorvastatin on kidney outcomes and cardiovascular disease in patients with diabetes: an analysis from the Collaborative Atorvastatin Diabetes Study (CARDS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCX040

Efficacy of rosuvastatin among men and women with moderate chronic kidney disease and elevated high-sensitivity C-reactive protein: a secondary analysis from the JUPITER (Justification for the Use of Statins in Prevention-an Intervention Trial Evalu

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCX040

Pravastatin and cardiovascular risk in moderate chronic kidney disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCX040

Simvastatin for secondary prevention of all-cause mortality and major coronary events in patients with mild chronic renal insufficiency.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCX040

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCX040

Long-term fluvastatin reduces the hazardous effect of renal impairment on four-year atherosclerotic outcomes (a LIPS substudy).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCX040

Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCX040

Effect of pravastatin on cardiovascular events in people with chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCX040

Focused atorvastatin therapy in managed-care patients with coronary heart disease and CKD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCX040

Intensive lowering of LDL cholesterol with 80 mg versus 20 mg simvastatin daily in 12,064 survivors of myocardial infarction: a double-blind randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCX040

Intensive lipid lowering with atorvastatin in patients with coronary heart disease and chronic kidney disease: the TNT (Treating to New Targets) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCX040

The second United Kingdom Heart and Renal Protection (UK-HARP-II) Study: a randomized controlled study of the biochemical safety and efficacy of adding ezetimibe to simvastatin as initial therapy among patients with CKD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCX040

Long-term cardiac outcomes in renal transplant recipients receiving fluvastatin: the ALERT extension study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCX040

Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCX040

Chronic kidney disease management in the United Kingdom: NEOERICA project results.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCX040

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCX040

Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCX040

21 January 2018

Identifiers

DOI

10.1093/QJMED/HCX040

1 reference

7 September 2017

1 reference

PubMed ID

28340216